Adia Nutrition Inc. Celebrates Adia Med's Approval as a UnitedHealthcare Provider in $5.3 Trillion Healthcare Market
Adia Nutrition Inc. (OTCQB: ADIA) has announced that its healthcare clinic, Adia Med, has received approval as a UnitedHealthcare provider, effective August 1, 2025. This strategic development positions Adia Med within the $5.3 trillion U.S. healthcare market, enabling access to its regenerative medicine treatments for UnitedHealthcare members.
Located in Winter Park, Florida, Adia Med specializes in minimally invasive therapies for orthopedic injuries, chronic pain, and wound repair. The clinic is staffed by physicians and Advanced Practice Registered Nurses (APRNs), offering personalized care using regenerative medicine treatments. The company is also seeking strategic partnerships and offering licensing opportunities for clinic owners interested in integrating Adia's regenerative therapies.
Adia Nutrition Inc. (OTCQB: ADIA) ha annunciato che la sua clinica sanitaria, Adia Med, ha ottenuto l'approvazione come fornitore di UnitedHealthcare, a partire dal 1 agosto 2025. Questo sviluppo strategico colloca Adia Med all'interno del mercato sanitario statunitense da 5,3 trilioni di dollari, permettendo ai membri di UnitedHealthcare di accedere ai suoi trattamenti di medicina rigenerativa.
Situata a Winter Park, Florida, Adia Med è specializzata in terapie minimamente invasive per lesioni ortopediche, dolore cronico e riparazione delle ferite. La clinica è composta da medici e infermieri specializzati (APRNs), offrendo cure personalizzate attraverso trattamenti di medicina rigenerativa. L'azienda sta inoltre cercando partnership strategiche e offre opportunità di licenza per i proprietari di cliniche interessati a integrare le terapie rigenerative di Adia.
Adia Nutrition Inc. (OTCQB: ADIA) ha anunciado que su clínica de salud, Adia Med, ha sido aprobada como proveedor de UnitedHealthcare, efectivo a partir del 1 de agosto de 2025. Este desarrollo estratégico posiciona a Adia Med dentro del mercado de salud de EE. UU. valorado en 5.3 billones de dólares, permitiendo que los miembros de UnitedHealthcare tengan acceso a sus tratamientos de medicina regenerativa.
Ubicada en Winter Park, Florida, Adia Med se especializa en terapias mínimamente invasivas para lesiones ortopédicas, dolor crónico y reparación de heridas. La clínica cuenta con médicos y enfermeros practicantes avanzados (APRNs), ofreciendo atención personalizada mediante tratamientos de medicina regenerativa. La compañía también busca alianzas estratégicas y ofrece oportunidades de licencia para propietarios de clínicas interesados en integrar las terapias regenerativas de Adia.
Adia Nutrition Inc. (OTCQB: ADIA)는 자사의 헬스케어 클리닉 Adia Med가 2025년 8월 1일부로 UnitedHealthcare 제공자로 승인받았다고 발표했습니다. 이 전략적 발전은 Adia Med를 미국 5.3조 달러 헬스케어 시장 내에 위치시키며, UnitedHealthcare 회원들이 재생 의학 치료에 접근할 수 있도록 합니다.
플로리다주 윈터파크에 위치한 Adia Med는 정형외과 부상, 만성 통증 및 상처 치료를 위한 최소 침습 치료를 전문으로 합니다. 이 클리닉은 의사와 고급 실무 간호사(APRNs)로 구성되어 있으며, 재생 의학 치료를 통해 맞춤형 케어를 제공합니다. 회사는 또한 전략적 파트너십을 모색하고 있으며, Adia의 재생 치료를 통합하려는 클리닉 소유주를 위한 라이선스 기회도 제공하고 있습니다.
Adia Nutrition Inc. (OTCQB: ADIA) a annoncé que sa clinique de santé, Adia Med, a été approuvée en tant que fournisseur UnitedHealthcare, à compter du 1er août 2025. Cette avancée stratégique positionne Adia Med sur le marché américain de la santé de 5,3 billions de dollars, permettant aux membres de UnitedHealthcare d'accéder à ses traitements de médecine régénérative.
Située à Winter Park, en Floride, Adia Med est spécialisée dans les thérapies peu invasives pour les blessures orthopédiques, la douleur chronique et la cicatrisation des plaies. La clinique est composée de médecins et d'infirmiers praticiens avancés (APRNs), offrant des soins personnalisés grâce à des traitements de médecine régénérative. L'entreprise recherche également des partenariats stratégiques et propose des opportunités de licence aux propriétaires de cliniques souhaitant intégrer les thérapies régénératives d'Adia.
Adia Nutrition Inc. (OTCQB: ADIA) hat bekannt gegeben, dass seine Gesundheitsklinik Adia Med ab dem 1. August 2025 als UnitedHealthcare-Anbieter zugelassen ist. Diese strategische Entwicklung positioniert Adia Med im 5,3 Billionen US-Dollar schweren US-Gesundheitsmarkt und ermöglicht UnitedHealthcare-Mitgliedern den Zugang zu seinen regenerativen Medizinbehandlungen.
Adia Med mit Sitz in Winter Park, Florida, spezialisiert sich auf minimalinvasive Therapien bei orthopädischen Verletzungen, chronischen Schmerzen und Wundheilung. Die Klinik wird von Ärzten und Advanced Practice Registered Nurses (APRNs) betreut und bietet personalisierte Versorgung mit regenerativen Medizinbehandlungen. Das Unternehmen sucht zudem strategische Partnerschaften und bietet Lizenzmöglichkeiten für Klinikinhaber, die Adias regenerative Therapien integrieren möchten.
- Secured provider status with major insurance company UnitedHealthcare
- Access to vast network of UnitedHealthcare members as potential patients
- Operating in a substantial $5.3 trillion healthcare market
- Offering licensing opportunities for business expansion
- Currently limited to single location in Winter Park, Florida
Winter Park, Florida--(Newsfile Corp. - August 6, 2025) - Adia Nutrition Inc. (OTCQB: ADIA) is proud to announce that its healthcare clinic, Adia Med, has been officially approved as a provider with UnitedHealthcare, effective as of August 1, 2025. This significant milestone positions Adia Med within the
UnitedHealthcare Logo
Cannot view this image? Visit:
https://images.newsfilecorp.com/files/10520/261181_unitedhealthcare_sign.jpg
Adia Med's integration into UnitedHealthcare's expansive network enhances its ability to deliver cutting-edge, minimally invasive therapies that promote faster recovery with minimal downtime, addressing conditions such as joint pain, sports injuries, and chronic wounds. This approval underscores Adia Nutrition's commitment to transforming patient care through regenerative solutions, ensuring patients can resume their active lifestyles efficiently and effectively.
"We are thrilled to join UnitedHealthcare's vast provider network, a pivotal step in bringing our regenerative treatments to a broader audience in this
Located in Winter Park, Florida, Adia Med is staffed by experienced physicians and autonomous Advanced Practice Registered Nurses (APRNs) who provide personalized, patient-centered care. The clinic leverages the latest advancements in regenerative medicine to address complex conditions, ensuring high-quality outcomes.
For questions, inquiries, or additional information, please contact Larry Powalisz at ceo@adiamed.com or by phone at 321-788-0850.
Clinic owners and healthcare practitioners interested in licensing the Adia Med name or integrating Adia's regenerative therapies into their practice are encouraged to reach out directly. Strategic partnerships are welcomed as part of Adia's continued mission to expand access to advanced stem cell solutions.
About ADIA Nutrition Inc.:
Adia Nutrition Inc. is a publicly traded company (OTCQB: ADIA) dedicated to revolutionizing healthcare and supplementation. With a focus on innovation and quality, the company has established two key divisions: a supplement division providing premium, organic supplements, and a medical division establishing Clinics that specialize in leading-edge stem cell therapies, most significantly Umbilical Cord Stem Cells (UCB-SC) and Autologous Hematopoietic Stem Cell Transplantation (aHSCT) treatments. Through these divisions, Adia Nutrition Inc. is committed to empowering individuals to live their best lives by addressing both nutritional needs and groundbreaking medical treatments.
Website: www.adianutrition.com
Website: www.adiamed.com
Website: www.adialabs.com
Website: www.biolete.com
Website: www.cementfactory.co
Twitter (X): @ADIA_Nutrition
Safe Harbor: This Press Release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a few uncertainties and risks that could significantly affect the company's current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company's business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commission and OTC Markets, Inc. OTC Disclosure and News Service. The company undertakes no obligation to publicly update or revise any forward-looking statements, because of new information, future events or otherwise.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/261181
FAQ
When did Adia Med become a UnitedHealthcare provider?
What treatments does Adia Med (OTCQB: ADIA) offer?
What is the market size for Adia Med's healthcare services?
How can healthcare practitioners partner with Adia Med?
Where is Adia Med's clinic located?
